The Natural Products Association (NPA) commends your leadership during this great crisis. We write to you today to raise an important issue that impacts the health of millions of Americans and the national economy.
A new report out today from the Food and Drug Administration (FDA) fails to offer a concrete plan on how the Agency will regulate CBD products. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy…
WASHINGTON — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor…
As part of ongoing efforts to ensure that consumers have access to accurate and meaningful information about the nutritional supplements and natural products they use each and every day, the Natural Products Association (NPA) announced its support for the…
Congress today punted on legislation to regulate the growing CBD industry and set a safe level of daily consumption. The conference report directs funding for research, policy evaluation, market surveillance, and enforcement discretion related to CBD and hemp. Unlike…
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.
